Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Personalized cardiac rehabilitation after an acute coronary event, focused on women and frail patients

Official title: Patient-centered Cardiac rehaBilitation pRogramE in Post Acute Coronary Syndrome:Identification of Key Barriers and Evaluation of Personalized Intervention (BREAK-trial)

Run by Institut d'Investigació Biomèdica de Bellvitge · NCT07038265 · Data updated 2026-11-12

This project will test a personalized, patient-centered cardiac rehabilitation program to see if it helps people—especially women and frail patients—recover better after an acute coronary syndrome.

More Frailty trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment202 (estimated)
SponsorInstitut d'Investigació Biomèdica de Bellvitge
Academic / other
Locations1 site (L'Hospitalet de Llobregat, Barcelona)
StatusRecruiting
StartedMay 26, 2025
Main results expectedNovember 2027
Study endsNovember 2027
Registry record updatedJune 26, 2025
Trial IDNCT07038265 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) discharged within 30 days after an acute coronary syndrome who can communicate and provide informed consent, particularly women and those identified as frail or with sarcopenia, are ideal candidates.

Probably not a fit

Patients who are institutionalized, have life expectancy under one year, have severe cognitive or psychiatric impairment without caregiver support, have planned major cardiac surgery or transplant, or cannot consent are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The BREAK-CR program is a single-center, open-label randomized controlled trial with blinded end-point adjudication that compares an integrated, multidisciplinary, patient-centered cardiac rehabilitation program to usual care for patients recently hospitalized with an acute coronary syndrome. The study begins with a qualitative phase to identify barriers and facilitators to program participation among women and frail patients and then implements a tailored intervention based on those findings. Key outcomes include feasibility, adherence, functional capacity, safety, patient satisfaction, and quality of life. Participants are randomized to the personalized program or standard cardiac rehabilitation and followed through program completion to compare incorporation and clinical outcomes.

Why it matters

Potential benefit: If successful, the program could increase enrollment and adherence to cardiac rehabilitation among women and frail survivors, improving functional recovery, satisfaction, and quality of life.

How similar studies have gone: Prior smaller and targeted rehabilitation programs have shown that tailored, gender-sensitive approaches can boost participation and outcomes, but comprehensive interventions explicitly designed for women and frail ACS survivors remain relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient aged ≥ 18 years
2. Patients discharged within the last 30 days after an admission for ACS or in the discharge planning process for an admission for ACS.
3. The patient is able to fully communicate with the research team and comply with all study procedures.
4. The patient voluntarily signs and dates the informed consent form approved by the ethics committee

Exclusion Criteria:

1. Age \<18 years
2. Participation in another clinical trial
3. Moderate or severe cognitive impairment in the absence of a competent caregiver
4. Absence of social support
5. Institutionalized patient
6. Life expectancy \<1 year
7. Candidates for end-of-life care
8. Severe psychiatric illness
9. Planned cardiac surgery including transplant or circulatory support implant
10. Death before hospital discharge in patients included in the hospital discharge planning phase
11. Carrier of heart transplant.
12. Patient unable or refusing to give written informed consent to participate
13. Patients who, in the opinion of the investigator, are unsuitable candidates for the study

Where it's running

  • Hospital Universitari de Bellvitge
    L'Hospitalet de Llobregat, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.